These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 30426452)

  • 1. LRRC8A potentiates temozolomide sensitivity in glioma cells via activating mitochondria-dependent apoptotic pathway.
    Yang C; He L; Chen G; Ning Z; Xia Z
    Hum Cell; 2019 Jan; 32(1):41-50. PubMed ID: 30426452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Honokiol enhances temozolomide-induced apoptotic insults to malignant glioma cells via an intrinsic mitochondrion-dependent pathway.
    Chio CC; Tai YT; Mohanraj M; Liu SH; Yang ST; Chen RM
    Phytomedicine; 2018 Oct; 49():41-51. PubMed ID: 30217261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of hsa_circ_0000936 sensitizes resistant glioma cells to temozolomide by sponging miR-1294.
    Hua L; Huang L; Zhang X; Feng H
    J Biosci; 2020; 45():. PubMed ID: 32975228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Connexin43 confers Temozolomide resistance in human glioma cells by modulating the mitochondrial apoptosis pathway.
    Gielen PR; Aftab Q; Ma N; Chen VC; Hong X; Lozinsky S; Naus CC; Sin WC
    Neuropharmacology; 2013 Dec; 75():539-48. PubMed ID: 23688923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. β-catenin contributes to cordycepin-induced MGMT inhibition and reduction of temozolomide resistance in glioma cells by increasing intracellular reactive oxygen species.
    Bi Y; Li H; Yi D; Bai Y; Zhong S; Liu Q; Chen Y; Zhao G
    Cancer Lett; 2018 Oct; 435():66-79. PubMed ID: 30081068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved effects of honokiol on temozolomide-induced autophagy and apoptosis of drug-sensitive and -tolerant glioma cells.
    Chio CC; Chen KY; Chang CK; Chuang JY; Liu CC; Liu SH; Chen RM
    BMC Cancer; 2018 Apr; 18(1):379. PubMed ID: 29614990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. lncRNA TUG1 inhibits the cancer stem cell‑like properties of temozolomide‑resistant glioma cells by interacting with EZH2.
    Cao Y; Chai W; Wang Y; Tang D; Shao D; Song H; Long J
    Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 34036375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of prolyl 4-hydroxylase, beta polypeptide (P4HB) attenuates temozolomide resistance in malignant glioma via the endoplasmic reticulum stress response (ERSR) pathways.
    Sun S; Lee D; Ho AS; Pu JK; Zhang XQ; Lee NP; Day PJ; Lui WM; Fung CF; Leung GK
    Neuro Oncol; 2013 May; 15(5):562-77. PubMed ID: 23444257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CHAC1-inhibited Notch3 pathway is involved in temozolomide-induced glioma cytotoxicity.
    Chen PH; Shen WL; Shih CM; Ho KH; Cheng CH; Lin CW; Lee CC; Liu AJ; Chen KC
    Neuropharmacology; 2017 Apr; 116():300-314. PubMed ID: 27986595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PLK1 inhibitor facilitates the suppressing effect of temozolomide on human brain glioma stem cells.
    Liu N; Hu G; Wang H; Li Z; Guo Z
    J Cell Mol Med; 2018 Nov; 22(11):5300-5310. PubMed ID: 30133120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GADD45A plays a protective role against temozolomide treatment in glioblastoma cells.
    Wang HH; Chang TY; Lin WC; Wei KC; Shin JW
    Sci Rep; 2017 Aug; 7(1):8814. PubMed ID: 28821714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1-Survivin axis.
    Tang JH; Yang L; Chen JX; Li QR; Zhu LR; Xu QF; Huang GH; Zhang ZX; Xiang Y; Du L; Zhou Z; Lv SQ
    Cancer Commun (Lond); 2019 Dec; 39(1):81. PubMed ID: 31796105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FOXO3a protects glioma cells against temozolomide-induced DNA double strand breaks via promotion of BNIP3-mediated mitophagy.
    He C; Lu S; Wang XZ; Wang CC; Wang L; Liang SP; Luo TF; Wang ZC; Piao MH; Chi GF; Ge PF
    Acta Pharmacol Sin; 2021 Aug; 42(8):1324-1337. PubMed ID: 33879840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circ_0005198 enhances temozolomide resistance of glioma cells through miR-198/TRIM14 axis.
    Deng Y; Zhu H; Xiao L; Liu C; Meng X
    Aging (Albany NY); 2020 Dec; 13(2):2198-2211. PubMed ID: 33316781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of ILK promotes temozolomide resistance in glioma cells.
    Liang F; Wang B; Bao L; Zhao YS; Zhang SM; Zhang SQ
    Mol Med Rep; 2017 Mar; 15(3):1297-1304. PubMed ID: 28138714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple Pathway-Dephosphorylated ASK-1 Confers Temozolomide-Resistance to Human Glioma Cells.
    Gao K; She K; Fan J; Shao L; Ji Z
    Turk Neurosurg; 2024; 34(1):67-73. PubMed ID: 36951032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chloroquine potentiates temozolomide cytotoxicity by inhibiting mitochondrial autophagy in glioma cells.
    Hori YS; Hosoda R; Akiyama Y; Sebori R; Wanibuchi M; Mikami T; Sugino T; Suzuki K; Maruyama M; Tsukamoto M; Mikuni N; Horio Y; Kuno A
    J Neurooncol; 2015 Mar; 122(1):11-20. PubMed ID: 25528635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of BRCA1-BRCA2-containing complex subunit 3 sensitizes glioma cells to temozolomide.
    Chai KM; Wang CY; Liaw HJ; Fang KM; Yang CS; Tzeng SF
    Oncotarget; 2014 Nov; 5(21):10901-15. PubMed ID: 25337721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cdc20 overexpression is involved in temozolomide-resistant glioma cells with epithelial-mesenchymal transition.
    Wang J; Zhou F; Li Y; Li Q; Wu Z; Yu L; Yuan F; Liu J; Tian Y; Cao Y; Zhao Y; Zheng Y
    Cell Cycle; 2017; 16(24):2355-2365. PubMed ID: 29108461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown of RLIP76 expression by RNA interference inhibits invasion, induces cell cycle arrest, and increases chemosensitivity to the anticancer drug temozolomide in glioma cells.
    Wang Q; Qian J; Wang J; Luo C; Chen J; Hu G; Lu Y
    J Neurooncol; 2013 Mar; 112(1):73-82. PubMed ID: 23292182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.